These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8640780)

  • 1. The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma.
    Prehn RT
    Cancer Res; 1996 Mar; 56(5):937-940. PubMed ID: 8640780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation of regression in primary melanoma with sentinel lymph node status.
    Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
    J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of transforming growth factor beta 1 and interleukin 10 in progressing and regressing areas of primary melanoma.
    Conrad CT; Ernst NR; Dummer W; Bröcker EB; Becker JC
    J Exp Clin Cancer Res; 1999 Jun; 18(2):225-32. PubMed ID: 10464712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and spontaneous regression of swine melanoma: relationship of in vitro leukocyte reactivity.
    Berkelhammer J; Ensign BM; Hook RR; Hecker CJ; Smith GD; Oxenhandler RW
    J Natl Cancer Inst; 1982 Mar; 68(3):461-8. PubMed ID: 6950174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete regression of primary malignant melanoma.
    Emanuel PO; Mannion M; Phelps RG
    Am J Dermatopathol; 2008 Apr; 30(2):178-81. PubMed ID: 18360126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic progression of metastatic melanoma.
    Rodolfo M; Daniotti M; Vallacchi V
    Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous regression in malignant melanoma].
    Avinoach I
    Harefuah; 1992 May; 122(9):587-92. PubMed ID: 1526586
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregnancy and the prognosis of malignant melanoma.
    Grin CM; Driscoll MS; Grant-Kels JM
    Semin Oncol; 1996 Dec; 23(6):734-6. PubMed ID: 8970595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous regression of metastases from malignant melanoma: a case report.
    Kalialis LV; Drzewiecki KT; Mohammadi M; Mehlsen AB; Klyver H
    Melanoma Res; 2008 Aug; 18(4):279-83. PubMed ID: 18626313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
    Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible key role of granzyme B in keratoacanthoma regression.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I
    Med Hypotheses; 2006; 66(6):1129-32. PubMed ID: 16497444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in skin cancer development and regression.
    Batinac T; Zamolo G; Ruzić A; Persić V
    Coll Antropol; 2007 Jan; 31 Suppl 1():23-8. PubMed ID: 17469744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.
    Cook MG; Spatz A; Bröcker EB; Ruiter DJ
    J Pathol; 2002 Jun; 197(2):188-93. PubMed ID: 12015742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia.
    Dunn GP; Lewis JS; Sunwoo JB; Uppaluri R
    Head Neck; 2008 Feb; 30(2):267-72. PubMed ID: 17657794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin melanomas.
    King R; Googe PB; Mihm MC
    Clin Lab Med; 2000 Dec; 20(4):713-29. PubMed ID: 11221511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors in thin cutaneous malignant melanoma].
    Massi D; Franchi A; Santucci M
    Pathologica; 2002 Dec; 94(6):282-9. PubMed ID: 12540991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially expressed genes in spontaneously regressing melanoma using the MeLiM swine model.
    Rambow F; Malek O; Geffrotin C; Leplat JJ; Bouet S; Piton G; Hugot K; Bevilacqua C; Horak V; Vincent-Naulleau S
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):147-61. PubMed ID: 18426408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta in cutaneous melanoma.
    Javelaud D; Alexaki VI; Mauviel A
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.